Designing and developing new drugs for the treatment of autoimmune diseases

First-in-class compounds modulating TCR signaling

Developing therapies selective to self-reactive T cells

A biopharmaceutical company dedicated to the development of new therapies for autoimmune and inflammatory diseases.